Documente Academic
Documente Profesional
Documente Cultură
PHRM 412
Thyroid gland
Thyroid: Meaning Shield shaped (the word introduced by Wharton) In mammals only this gland has capacity to incorporate iodine into organic substances: invented by Baumann
Thyroid gland
The gland is highly vascular and flat structure The thyroid gland has a blood flow about five times the weight of the gland each minute Located at the upper portion of the trachea and just below the larynx
Thyroid gland
Large gland, bi-lobed, connected by a central isthmus
Thyroid gland
Two class of hormones are secreted: Iodide containing hormones of two types T3 triiodothyronine Both of these hormones profoundly increase the T4 thyroxine metabolic rate of the body. Thyrocalcitonin A hormone, also called calcitonin,
produced by the thyroid gland that lowers the levels of calcium and phosphate in the blood and promotes the formation of bone.
Thyroid gland
Complete lack of thyroid secretion usually causes the basal metabolic rate to fall 40 to 50 percent below normal Extreme excesses of thyroid secretion can increase the basal metabolic rate to 60 to 100 percent above normal
Thyroid-stimulating hormone
Thyroid-stimulating hormone
Thyroid gland
Thyroid gland: functional units is follicles. Follicle consists of a luminal cavity surrounded by a one-cell-deep layer of cells called follicular or acinar cells. The center of the follicles is filled with a gelatinous colloid, the main component of which is a glycoprotein called thyroglobulin.
Thyroglobulin
Follicular cell
Requirement of iodine
To form normal quantities of thyroxine, about 50 milligrams of ingested iodine in the form of iodides are required each year, or about 1 mg/week. To prevent iodine deficiency, common table salt is iodized with about 1 part sodium iodide to every 100,000 parts sodium chloride.
Triiodothyronine is about four times as potent as thyroxine, but it is present in the blood in much smaller quantities and persists for a much shorter time than does thyroxine.
Hyperthyroidism
Two types: Diffuse toxic goiter or Graves disease Toxic nodular goiter or Toxic multinodular goiter or Plummer's disease
Hyperthyroidism
Also called Graves disease, Basedows disease, thyrotoxicosis, or exophthalmic goiter. Thyroid gland: increase two to three times of normal size (tremendous hyperplasia and in folding of the follicular cell lining into the follicles, so that the number of cells is increased greatly) Each cell increases its rate of secretion several fold (at rates 5 to 15 times normal)
Graves' disease
Graves' disease is an autoimmune disease where the thyroid gland is overactive, producing an excessive amount of thyroid hormones (a serious metabolic imbalance known as hyperthyroidism and thyrotoxicosis).
Graves' disease
This is caused by autoantibodies to the TSHreceptor (TSHR-Ab) that activate that TSHreceptor (TSHR), thereby stimulating thyroid hormone synthesis and secretion, and thyroid growth (causing a diffusely enlarged goiter).
*Plasma TSH concentrations are less than normal rather than enhanced in almost all patients and often are essentially zero
Hyperthyroidism: Symptoms
Symptoms are from mild to severe Restless despite feeling fatigued and weak, highly excitable, and constantly agitated Fine tremors of the hands occur, resulting in unusual clumsiness
Antithyroid drugs
The best known antithyroid substances are: Thiocyanate ion, thioamides, and high concentrations of inorganic iodides.
6-propyl-2-thiouracil
1-methylimidazole-2-thiol
Structure of thioamides
Structure-activity relationships
The C2 thioketo/ thioenol group and an unsubstituted N1 position are essential for activity of six membered thioamides.
Structure-activity relationships
The enolic hydroxyl group at C4 in PTU and the presence of alkyl group at C5 and C6 enhance the inhibitory potency.
Structure-activity relationships
Methimazole has more TPO inhibitory activity and is longer -acting than PTU but , in contrast to PTU, is not able to inhibit the peripheral deiodination of T4, presumably because of the presence of the methyl group at N1 position.
1
Structure-activity relationships
Efforts to improve the taste and decrease the rate of release of methimazole led to the development of carbimazole. Carbimazole, the pro-drug derivative of methimazole, gives rise to methimazole in vivo and is used in the same dosage.
Radioiodine therapy
Definitive treatment: given primarily to destroy the hyperfunctioning thyroid tissue. Available as Sodium iodide I 131 (Na131I)
Radioiodine therapy
Radioiodine is an oral medication and given as single dose. Patients taking radioiodine therapy, few required more than one dose. Usual dose: 100 to 200 Ci per gram of weight of thyroid gland.
Radioiodine therapy
Radioiodine is taken by the follicular cell in the same way as iodine and beta emission of radioiodine causes necrosis and decrease the activity of thyroid tissue.
Radioiodine therapy
The cell necrosis induced by radioiodine occurs gradually. May elapse hyperthyroidism (after 6-18 weeks or later of the treatment) before a hypothyroid or euthyroid state is achieved. If previously used: Antithyroid drugs: 3-7 days beta-adrenergic blocking agents: continued
Radioiodine therapy
Pregnancy: Sodium iodide I 131 has been shown to cause harm to a developing fetus. Use in pregnant women should be avoided. Nursing mother: Iodine is excreted in breast milk. Therefore, formula feedings for infants are strongly recommended for nursing women requiring sodium iodide I 131 treatment.
Radioiodine therapy
The side effects commonly seen with sodium iodide I 131 treatment are mild with the smaller doses given for hyperthyroidism but may be more severe with the larger doses given for thyroid cancer.
Radioiodine therapy
Sodium iodide I 131 may cause suppression of the bone marrow, resulting in anemia, and reductions in white blood cells and platelets. Increased risk of death from cardiovascular disease.